Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell cycle regulation is the complex network of molecular mechanisms that control the progression and timing of cell division. This process ensures that cells only divide when appropriate, maintaining tissue homeostasis and preventing uncontrolled proliferation, which can lead to diseases such as cancer. Key components include cyclins, cyclin-dependent kinases (CDKs), the Anaphase-Promoting Complex/Cyclosome (APC/C), and checkpoint proteins like Rb, p53, and p21. Regulation occurs through internal and external signals and checkpoints that monitor DNA replication, chromosome segregation, and overall cellular integrity. Dysregulation can result in uncontrolled proliferation, a hallmark of cancer, and many anti-cancer therapies target components like CDKs or proteasomal degradation pathways involved in this regulatory system.
CDK inhibitors: Block cell cycle progression by inhibiting cyclin-dependent kinases. Proteasome inhibitors: Disrupt protein degradation pathways, leading to cell cycle arrest and apoptosis. DNA damaging agents: Induce DNA damage, triggering cell cycle checkpoints and potentially apoptosis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell Cycle Regulation.